High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update
published in: The Cancer Journal from Scientific American
date of publication: 2000-02-01
main subject: patient, interleukins, metastatic melanoma
Cites articles
There is nothing here
Article - wd:Q34507305